FIG. 2.
Dynamics of HBV variant populations before and during lamivudine therapy in patients A to D (panels A, B, C, and D, respectively). This figure illustrates the respective losses and gains of in vivo fitness by the different HBV populations over time, relative to treatment outset and virological breakthroughs. M, month.